An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist
Authors: Diamond LE, Earle DC, Heiman JR, Rosen RC, Perelman MA, et al.
Journal
J Sex Med
Year
2006
Citations
400
Type
Research Article
Subject
Human
Condition
Sexual Dysfunction
TL;DR
Study investigating bremelanotide (PT-141), a melanocortin receptor agonist, for improving subjective sexual response in premenopausal women with sexual arousal disorder.
View Paper
DOI: 10.1111/j.1743-6109.2006.00268.x
Abstract
Study investigating PT-141 (Bremelanotide): An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist.